Clinical trial
PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancer
NCT00379561 · Sophiris Bio Corp, Industry · Completed
Key facts
| NCT number | NCT00379561 |
|---|---|
| Title | PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancer |
| Official title | A Phase 1 Trial of PSA-Activated PSA-PAH1 Therapy for Locally Recurrent Prostate Cancer Without Metastases After Primary Radiation Therapy |
| Lead sponsor | Sophiris Bio Corp, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | PSA-Activated PSA-PAH1 |
| Enrollment | 24 |
| Start date | Mar 1, 2006 |
| Primary completion | May 1, 2007 |
| Completion | Jul 1, 2008 |
| First posted | Sep 22, 2006 |
| Last update posted | Oct 29, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: